UCITS · Ireland · Accumulating
R2EH IE000WFBC0W4
US small-cap stocks (hedged to EUR)
State Street SPDR Russell 2000 U.S. Small Cap EUR Hdg UCITS ETF (Acc)
State Street (SPDR)
1,932 holdings as of 2026-10-09 · top 10 = 3.3% · TER 0.35% · P/E 19.4
Add to portfolioStart with this fund, then add the others you hold.
Concentration
Well diversifiedtop 10 = 3.3%
diversifiedconcentrated
GROWTH · PRICE DEVELOPMENTrebased to 0%
Holdings
1,932
as of 2026-10-09
Top 10
3.3%
TER
0.35%
cheaper than 31% of peers
Net assets
€4.87B
reported in EUR
Largest
0.4%
P / E
19.4
covers 65% by weight
Sections
Holdings as of 2026-10-09.
01Overview
Distribution
Accumulating
Fund currency
EUR
Domicile
Ireland
Structure
Open-ended
First listed
2026-06-15
Tracked index
Russell 2000 Net of Tax 100% Hedged to EUR Index
How it tracks
Physical, optimised
Risk rating
5 of 7
Lends its stock
Yes
02Valuation and performance
1M
-4.1%
3M
–
6M
–
YTD
–
1Y
–
Valuation1,724 companies covered · weighted, profitable holdings only
19.4
price / earnings
MethodologyCompany-data coverageThe rest is 34% loss-making companies, which carry no P/E by the positive-earner convention; 1% cannot be reliably linked to the financial and market data used in this analysis. We exclude uncertain matches rather than estimate them.
-0.1%
MethodologyEarnings yieldP/E is price over earnings; earnings yield is the reverse, earnings over price, and reads like a bond yield. P/E covers only the profitable holdings, since a loss-making company has no meaningful P/E. Earnings yield counts the loss-makers too, so it covers more of the fund and can fall below zero when the holdings lose money overall.
covers 98% by weight
2.00
price / book
covers 88% by weight
Computed from company filings and reported position values. MethodologyPortfolio valuationComputed by us from each company's own financial statements and the position values funds report, currency-adjusted and weighted harmonically. P/E covers profitable holdings only. Book value uses the most recent reported quarter.. Not investment advice.
03Holdings
| # | Company | Identifier | Weight |
|---|---|---|---|
| 1 | JFROG LTD IL | FROG | |
| 2 | BRIGHTSPRING HEALTH SERVICES, INC. US | BTSG | |
| 3 | TWIST BIOSCIENCE CORP US | TWST | |
| 4 | MOOG INC. US | MOG/A | |
| 5 | Vaxcyte, Inc. US | PCVX US | |
| 6 | GLAUKOS CORPORATION US | GKOS | |
| 7 | UMB Financial Corp US | UMBF | |
| 8 | 10X GENOMICS INC-CLASS A US | TXG | |
| 9 | Viasat Inc US | VSAT | |
| 10 | SM Energy Co US | SM | |
| 11 | Protagonist Therapeutics Inc US | PTGX | |
| 12 | InterDigital Inc US | IDCC | |
| 13 | HUT 8 CORP. US | HUT US | |
| 14 | FIRSTCASH HOLDINGS, INC. US | FCFS | |
| 15 | Krystal Biotech Inc US | KRYS | |
| 16 | Caretrust Reit Inc US | CTRE | |
| 17 | Cytokinetics Inc US | CYTK | |
| 18 | Jackson Financial Inc US | JXN | |
| 19 | MAXLINEAR, INC. US | MXL | |
| 20 | PBF ENERGY INC. US | PBF | |
| 21 | BRINKER INTERNATIONAL, INC. US | EAT | |
| 22 | Ryman Hospitality Properties Inc US | RHP | |
| 23 | OLD NATIONAL BANCORP US | ONB | |
| 24 | Oscar Health Inc US | OSCR | |
| 25 | TG THERAPEUTICS, INC. US | TGTX | |
| 26 | HEALTHEQUITY, INC. US | HQY | |
| 27 | Zeta Global Holdings Corp US | ZETA | |
| 28 | SSR Mining Inc US | SSRM | |
| 29 | ARCOSA, INC. US | ACA | |
| 30 | SILICON LABORATORIES INC. US | SLAB | |
| 31 | Qualys Inc US | QLYS | |
| 32 | Commercial Metals Co US | CMC | |
| 33 | Fluor Corp US | FLR | |
| 34 | Kymera Therapeutics Inc US | KYMR US | |
| 35 | Plexus Corp US | PLXS | |
| 36 | ZURN ELKAY WATER SOLUTIONS CORPORATION US | ZWS | |
| 37 | TERRENO REALTY CORP US | TRNO | |
| 38 | FEDERAL SIGNAL CORPORATION US | FSS | |
| 39 | Matson Inc US | MATX | |
| 40 | ESCO TECHNOLOGIES INC. US | ESE | |
| 41 | Alkermes PLC IE | ALKS | |
| 42 | COMPASS, INC US | COMP US | |
| 43 | StoneX Group Inc US | SNEX | |
| 44 | HIMS & HERS HEALTH, INC. US | HIMS | |
| 45 | Enpro Inc. US | NPO | |
| 46 | Lantheus Holdings Inc US | LNTH | |
| 47 | EnerSys US | ENS | |
| 48 | COMMVAULT SYSTEMS, INC. US | CVLT | |
| 49 | Spyre Therapeutics, Inc. US | SYRE | |
| 50 | Praxis Precision Medicines Inc US | PRAX US |
04Exposure
Equity 100.0%
By sector
Healthcare20.0%
Financial Services18.7%
Industrials14.0%
Technology13.8%
Consumer Cyclical9.0%
Energy6.7%
Real Estate5.6%
Materials4.2%
Utilities2.8%
Communication Services2.4%
Consumer Defensive2.0%
By country
USUnited States93.6%
BMBermuda1.2%
CACanada1.2%
KYCayman Islands0.7%
CHSwitzerland0.6%
ILIsrael0.5%
IEIreland0.5%
GBUnited Kingdom0.3%
CurrencyUSD 95.7% CAD 1.2% EUR 0.7% CHF 0.6% ILS 0.5%
Issuer's scenario analysisaverage return per year over 5 years
Stress
-24.7%
Unfavourable
-0.5%
Moderate
+5.7%
Favourable
+14.8%
06Where it trades
| Exchange | MIC | Listed since |
|---|---|---|
| Euronext Paris | XPAR | 2026-06-17 |
Also admitted to 9 other venues, mostly multilateral trading facilities and regional segments.
See this fund inside your whole portfolio
Paste every fund you hold and see the companies you actually own, merged across all of them, with overlap, concentration and portfolio P/E. You can also test what adding this ETF would change.